
RGCIRC launches campaign for early oral cancer detection, Health News, ET HealthWorld
By ,
ETHealthWorld
Join the community of 2M+ industry professionals Subscribe to our newsletter to get latest insights & analysis.
Download ETHealthworld App Get Realtime updates
Save your favourite articles
Scan to download App
New Delhi: Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC), Rohini, New Delhi, in association with Merck Specialities Private Limited has launched the 'Two-Minute Action for Oral Cancer Protection' campaign with the hashtag #ActAgainstOralCancer.The campaign aims to tackle the alarming rise in oral cancer cases by encouraging individuals to perform a quick self-check using mirrors that are almost always available to one and all. The stated message of the campaign is: Look, Feel, and Act.According to the institute, mirror checks can help identify early signs of oral cancer , potentially enabling timely treatment.As part of the initiative, mirrors will be placed in hospital waiting areas to encourage visitors to perform self-checks.Dr. (Prof) Sudhir Kumar Rawal, Medical Director, RGCIRC said, 'Head and neck cancer is very common in India. These types of cancers are lifestyle-related, and linked to the rampant use of tobacco and alcohol in society. The treatment of this cancer, especially when detected early, is much more effective.'Dr. A.K. Dewan, Director, Surgical Oncology, RGCIRC stated, 'Gutkha, smoking, alcohol consumption, poor oral hygiene, and certain viral infections, especially Human Papillomavirus (HPV) are key risk factors contributing to the rising incidence of throat cancers.''There should be awareness on the common early signs and symptoms of oral cancers like white patches, red patches, referred ear pain, and nonhealing ulcers.' said Dr. Mudit Agarwal, Unit Head & Senior Consultant, Head & Neck Oncology, RGCIRC.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
6 hours ago
- Time of India
AIIMS-R VRDL gets 1st NABL accreditation for diagnosis of 12 major viral infections
Raipur: The state viral research and diagnostic laboratory (VRDL) at the All India Institute of Medical Sciences (AIIMS), Raipur, has received its first accreditation from the National Accreditation Board for Testing and Calibration Laboratories (NABL). The laboratory, which functions under the Department of Microbiology, was accredited for the diagnosis of 12 major viral infections. These include viral meningitis and encephalitis, COVID-19 (SARS-CoV-2), swine flu (H1N1), influenza B, respiratory syncytial virus (RSV), and 14 high-risk human papillomavirus (HR-HPV) types that cause cervical cancer. The list also includes Epstein-Barr virus (EBV), Herpes simplex virus (HSV), cytomegalovirus (CMV), Hepatitis B and C viral load, and dengue. Established in 2018, the VRDL provides diagnostic services to patients at AIIMS Raipur and receives samples from across Chhattisgarh. It is involved in testing for COVID-19, Hepatitis A, B, C, E, and dengue. The lab also assists in investigating outbreaks of viral diseases like chickenpox, conjunctivitis, and mumps. The VRDL is the state nodal centre for COVID-19 testing, quality control, and whole genome sequencing of SARS-CoV-2. Lt Gen Ashok Jindal (Retd), Executive Director and CEO of AIIMS Raipur, congratulated the team for their achievement, stating that the NABL accreditation is a step towards national recognition for the diagnostic services provided to the people of Chhattisgarh. Prof Dr Anudita Bhargava, who heads the Department of Microbiology, said the recognition was the result of teamwork and dedication by the entire staff. Prof. Dr Sanjay Singh Negi stated that the accreditation, which follows the ISO 15189:2022 standards, reflects the high quality of the diagnostic testing. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area.


Time of India
19 hours ago
- Time of India
Michael Douglas cancer diagnosis: What did the 'Basic Instinct' star think caused the cancer and what it actually was
Even the 'Basic Instinct' star wasn't immune, as it seems. In 2010, Hollywood icon Michael Douglas publicly revealed he was battling stage IV throat cancer. He initially thought stress, years of smoking, and heavy drinking might have played a role. However, as facts emerged, it became clear the cancer was linked to a different culprit altogether. What was it? What did Michael Douglas think caused his cancer (and what it really was) When diagnosed in August 2010, Douglas publicly suggested that long-term alcohol and tobacco use, along with stress, might have contributed to his cancer. He admitted that stress, especially relating to his son's incarceration at the time, also weighed on his mind. Later, in a candid 2013 interview, the American actor and producer mentioned human papillomavirus (HPV) tied to oral sex as a possible cause. In a quite uncanny manner, parallels were drawn between him starring in films like 'Basic Instinct', 'Fatal Attraction', and so on. His initial symptoms, like persistent throat or ear pain, were misdiagnosed as infection, until a physician in Montreal peered deep into his throat and a tumor was spotted at the base of his tongue. A biopsy confirmed stage IV squamous cell carcinoma of the tongue, an advanced form of oral cancer, prompting immediate treatment with chemotherapy and radiation. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Efail Isaf: If You Were Born Between 1940-1975 You Could Be Eligible For This Life Cover Reassured Get Quote Undo The real culprit: HPV, not habits In 2013, Douglas made headlines when he suggested his cancer was caused by HPV, a sexually transmitted virus, possibly contracted through oral sex. He remarked: 'this particular cancer is caused by HPV … which actually comes about from cunnilingus.' However, his representatives clarified he was speaking broadly about HPV-linked cancers, not necessarily his own case. They added that he did not definitively state that oral sex caused his personal cancer, and emphasized that HPV is a known risk factor for oropharyngeal cancers, but not necessarily the direct cause in every case. What is HPV and why does it matter in oral cancer HPV, or Human Papillomavirus, is a common viral infection that can cause various health problems. It is primarily transmitted through sexual contact and affects the skin and mucous membranes, with over 200 identified types. While many HPV infections are harmless and resolve on their own, some types can lead to serious complications like genital warts and certain cancers. HPV is categorized into low-risk and high-risk types. Low-risk HPV: These types can cause genital warts but are not typically associated with cancer. High-risk HPV: These types can lead to various cancers, including cervical, vaginal, penile, anal, and throat cancers. HPV is now recognized as a major risk factor for this type of cancer, particularly in the back of the throat, tonsils, and base of the tongue. While HPV infection is common, it usually clears up on its own. However, in some cases, it can persist and lead to the development of cancer years later. HPV-related throat cancers are becoming increasingly common. In fact, HPV now accounts for a majority of oropharyngeal cancer cases, especially among men. These cancers often strike adults who are non-smokers and non-heavy drinkers. What is squamous cell carcinoma? Squamous cell carcinoma (SCC) is a type of cancer that develops from squamous cells, which are flat, scale-like cells found in the skin and other tissues. It's the second most common type of skin cancer, after basal cell carcinoma, and can also occur in other areas like the lungs, head and neck, and cervix. SCC is often caused by prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds. Squamous cells are a type of epithelial cell, meaning they form the lining of surfaces throughout the body, including the skin, respiratory tract, and digestive tract. They are flat and scale-like, resembling fish scales under a microscope. While SCC is commonly found on sun-exposed areas of the skin like the face, scalp, and hands, it can also develop in other locations, including: Skin: This is the most common site. Lungs: Lung cancer can sometimes be of the squamous cell type. Head and neck: This includes cancers of the mouth, throat, and voice box. Cervix: Cervical cancer can also be squamous cell carcinoma. Other locations: SCC can also occur in the nasal cavity, sinuses, and tear ducts. Can HPV cause SCC? Some types of Human Papillomavirus (HPV) can cause squamous cell carcinoma (SCC). Specifically, high-risk HPV types, like HPV-16 and HPV-18, are strongly linked to the development of certain squamous cell carcinomas, particularly in the oropharynx (the middle part of the throat). HPV infection is a significant risk factor for oropharyngeal squamous cell carcinoma (OPSCC). Risk factors SCC risk factors include excessive sun exposure, fair skin, a history of sunburns, older age, male gender, immunosuppression, and certain genetic syndromes apart from those stemming from HPV. Lifestyle factors like smoking and heavy alcohol consumption also increase the risk. Additionally, chronic wounds, exposure to radiation or arsenic, and a history of other skin cancers can be contributing factors. Let's take a detailed look: Ultraviolet (UV) radiation exposure: Sun exposure is the most significant risk factor, particularly for cutaneous squamous cell carcinoma (cSCC). Cumulative sun damage over time, especially during youth, increases the risk. Fair skin: Individuals with fair skin (Fitzpatrick skin types I-III) are more susceptible due to lower melanin levels, which offer less protection against UV radiation. Age: The incidence of SCC rises with age, with most cases occurring in individuals over 50. Gender: Males are generally at a higher risk of developing SCC compared to females. Immunosuppression: Weakened immune systems, often due to medications or organ transplants, make individuals more vulnerable to SCC. Genetic predisposition: Certain inherited conditions and genetic mutations (like TP53, CDKN2A, Ras, and NOTCH1) can increase susceptibility to SCC. Smoking and alcohol consumption: Heavy smoking and excessive alcohol intake are strongly linked to SCC, particularly in the oral cavity and esophagus. Chronic wounds and scarring: Persistent wounds, burns, or scars can create an environment where SCC can develop. Arsenic exposure: Long-term exposure to arsenic, through drinking water or occupational settings, can increase the risk of SCC. Actinic keratosis: These are precancerous skin lesions caused by sun damage and are a significant risk factor for cSCC. Oral hygiene: Poor oral hygiene and dental problems can contribute to oral SCC. Family history: A family history of skin cancer can increase an individual's risk of developing SCC. Prevention and treatment To prevent squamous cell carcinoma (SCC) of the skin, it's crucial to minimize sun exposure and avoid tanning beds. Regularly using sunscreen with at least SPF 30, seeking shade during peak sun hours, and wearing protective clothing like hats and long sleeves are essential steps. Annual skin exams, especially for those with risk factors like a history of sun exposure or family history of skin cancer, are also recommended. Squamous cell skin cancer treatment options include surgery (excision, Mohs surgery), radiation therapy, and topical or systemic medications, depending on the cancer's size, location, and stage. For early-stage, small cancers, less invasive procedures like curettage and electrodesiccation, cryosurgery, or photodynamic therapy might be sufficient. For advanced cases, or when surgery is not an option, radiation therapy or medications like imiquimod or 5-fluorouracil may be used. In the case of Douglas, the actor underwent aggressive chemotherapy and radiation treatments and has been cancer-free since 2011, though he continues with regular check-ups. Sanjay Dutt on his battle with cancer: 'It all comes down to willpower and keeping the faith'


The Hindu
2 days ago
- The Hindu
RFK Jr.'s vow to overhaul vaccine injury program echoes grievances of anti-vaccine movement
Health Secretary Robert F. Kennedy Jr. is vowing to 'fix' the federal programme for compensating Americans injured by vaccines, opening the door to sweeping changes for a system long targeted by anti-vaccine activists Vaccine Injury Compensation Program history and purpose Health experts and lawyers say updates are needed to help clear a backlog of cases in the Vaccine Injury Compensation Program, created by Congress in 1986 as a no-fault payment system for presumed vaccine injuries. But they also worry Kennedy's changes will reflect his history as a leader in the anti-vaccine movement, which has alternately called for abolishing the program or expanding it to cover unproven injuries and illnesses that aren't connected to vaccines. Kennedy and other critics believe the programme is 'too miserly in what it considers to be a vaccine injury,' said Jason Schwartz, a public health expert at Yale University. 'That's created great concern that he could expand what's included.' Anti-vaccine groups have long suggested a link between vaccines and autism, despite scientific consensus that childhood vaccines don't cause the condition. Adding autism to the list of injuries covered by the plan 'would dramatically increase the number of compensable cases, potentially bankrupting it," Schwartz said. Signed into law under President Ronald Reagan, the compensation programme is designed to provide quick, efficient compensation to Americans who report known injuries associated with vaccines, such as rare allergic reactions. At the time of its creation, a number of vaccine-makers were exiting the business due to risks of class action lawsuits. In a recent social media post, Kennedy called the programme 'broken' and accused federal lawyers and adjudicators who run it of 'inefficiency, favoritism and outright corruption.' Kennedy didn't specify the changes he's seeking. But some of the people he's enlisted to help have a history of bringing vaccine injury cases. In June, the Department of Health and Human Services awarded a $150,000 contract to an Arizona law firm for 'expertise' in the programme. The firm's Andrew Downing, an attorney specialising in vaccine injury cases, was listed in the HHS staff directory for a time. 'We just brought a guy in this week who is going to be revolutionizing the Vaccine Injury Compensation Program,' Kennedy told Tucker Carlson shortly after the award. Revamping the program would be the latest in a string of decisions that have upended U.S. vaccine policy, including this week's cancellation of research funding for vaccines using mRNA technology. Potential impacts of Kennedy's proposed changes Downing has had a leading role in lawsuits against Merck alleging injuries from its HPV vaccine, Gardasil, including a rare movement disorder. In a podcast last year for people with the condition, Downing lamented that the injury compensation programme 'has taken a hard line' against such cases, leading lawyers to file injury lawsuits in civil court. Approximately 70% of the Gardasil cases against Merck started as claims filed by Downing in the federal injury program, according to court records. A judge dismissed more than 120 of those cases, citing 'a paucity of evidence" that Gardasil caused patients' problems. A spokesman for Kennedy declined to comment on Downing's hiring. Kennedy himself has been involved in the Gardasil litigation, as both an attorney and consultant. Before joining the government, Kennedy received payments for referring potential Gardasil clients to Wisner Baum, one of the law firms suing Merck. Following questions about the agreement during his confirmation hearings, Kennedy agreed to give up his stake in the deal and transfer any future fees to 'a nondependent, adult son," according to his financial disclosures. One of Kennedy's sons is an attorney at Wisner Baum. Experts who study vaccine compensation say real changes are needed to modernise the 40-year-old programme. Existing gaps and proposed updates to the system The cap on compensation remains $250,000 for injury or death, the same as in 1986. Similarly, the program still has eight adjudicators, known as special masters, to review all cases before the government. On average, the process takes two to three years. The fund has paid out $5.4 billion, compensating about 40% of all people who filed claims. The U.S. has an 'ethical obligation' to promptly pay those harmed by government-recommended vaccines, says Dorit Reiss, a professor at the University of California Hastings College of the Law.'Plus, I think it increases trust in the vaccination program if you have quick, generous compensation,' Reiss said. As health secretary, Kennedy has broad powers to reshape the programme. One approach could be adding new diseases and illnesses to the government table of payable injuries. In the early 2000s, the program ruled against more than 5,000 claims from families who said vaccines led to their children's autism, citing hundreds of scientific studies discrediting the link. Critics of Kennedy say he could claim that he has new evidence of harm — perhaps from a large autism study he's commissioned — and add the condition to the program. In response, the federal government might have to increase taxes on vaccines to replenish the compensation fund, which would make the shots more expensive and less accessible. 'Then you will start to watch the vaccine programme infrastructure in this country disintegrate until someone steps in,' Dr. Paul Offit, a vaccine researcher at Children's Hospital of Philadelphia who has clashed with Kennedy for years. A recent Senate hearing titled 'Voice of the Vaccine Injured' appeared to make the case for expanding the programme. Witnesses included two representatives from Children's Health Defense, the nonprofit group that Kennedy previously chaired and has repeatedly sued the government over vaccines. The group's chief science officer, Brian Hooker, told lawmakers he tried unsuccessfully for 16 years trying to get compensation for his son's autism, which he attributes to the measles-mumps-rubella vaccine. Another approach would involve removing certain vaccines from the program, making it easier to bring lawsuits against vaccine-makers. Under current law, people claiming injuries from vaccines covered by the program must first pursue a compensation claim before they can sue. In cases where the science doesn't support a connection to vaccines, lawyers might be more successful before a jury. 'Jury trials take advantage of the fact that most jurors don't know anything about science or medicine,' Offit said. 'They are not going to be as easily moved by the data.' Still, attorneys who bring cases before the compensation program say the process has become more burdensome and adversarial over the years. Even small changes could improve things. For instance, the statute of limitations for claims could be extended beyond the current three years, which lawyers say cuts off many potential clients. 'I'm hoping there will be changes put in place that make the programme easier for petitioners to navigate' said Leah Durant, a vaccine injury attorney.